These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35331175)

  • 1. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
    Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
    BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
    Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
    J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
    Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
    Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.
    Chen H; Zhang J; Zhou H; Zhu Y; Liang Y; Zhu P; Zhang Q
    Front Oncol; 2022; 12():934145. PubMed ID: 35965551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
    Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study.
    Cao B; Yang S; Yan L; Li N
    Cancer Biomark; 2023; 37(4):289-297. PubMed ID: 37302027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
    Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
    Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
    [No Abstract]   [Full Text] [Related]  

  • 10. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
    Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
    Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome.
    Gao Y; Li J; Fan S; Chen P; Huang M; Bi H
    Front Endocrinol (Lausanne); 2022; 13():895116. PubMed ID: 35846297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma.
    Wang Z; Guo X; Wang W; Gao L; Bao X; Feng M; Lian W; Zhu H; Xing B
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e273-e287. PubMed ID: 33031533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
    Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics.
    Merciai F; Musella S; Sommella E; Bertamino A; D'Ursi AM; Campiglia P
    J Chromatogr A; 2022 Jun; 1673():463124. PubMed ID: 35567813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
    Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
    Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.
    Zhi Y; Sun Y; Jiao Y; Pan C; Wu Z; Liu C; Su J; Zhou J; Shang D; Niu J; Hua R; Yin P
    Front Pharmacol; 2021; 12():754185. PubMed ID: 34880754
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipidomics for Determining Giant Panda Responses in Serum and Feces Following Exposure to Different Amount of Bamboo Shoot Consumption: A First Step towards Lipidomic Atlas of Bamboo, Giant Panda Serum and Feces by Means of GC-MS and UHPLC-HRMS/MS.
    Zhu C; Pan X; Li G; Li C; Wu D; Tang J; Huang Y; Zou L; Laghi L
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
    Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
    Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.